Cite

HARVARD Citation

    Saito, M. et al. (2016). A soluble form of Siglec-9 provides a resistance against Group B Streptococcus (GBS) infection in transgenic mice. Microbial pathogenesis. pp. 106-110. [Online]. 
  
Back to record